FAKTOR OPTIONSSCHEIN - SMITH & NEPHEW | Real-time BOERSE MUENCHEN 10:26:18 2024-06-05 am EDT | ||
| 1.94 EUR | -45.51% |
|
| Current month | -1.93% | ||
| 1 month | -8.48% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
| Date | Price | Change |
|---|---|---|
| 24-06-05 | 1.94 | -45.51% |
| 24-06-04 | 3.56 | -10.55% |
| 24-06-03 | 3.98 | +9.64% |
| 24-05-31 | 3.63 | -4.22% |
| 24-05-30 | 3.79 | -14.06% |
Real-time BOERSE MUENCHEN
Last update June 05, 2024 at 10:26 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Goldman Sachs |
| WKN | GG1RGT |
| ISIN | DE000GG1RGT4 |
| Date issued | 2024-01-03 |
| Strike | 1,072 p |
| Maturity | Unlimited |
| Parity | 0.28 : 1 |
| Emission price | 13.38 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.45 € |
|---|---|
| Lowest since issue | 1.94 € |
| Spread | 0.1 € |
| Spread % | 5.15% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.72
USD
Average target price
16.43
USD
Spread / Average Target
+29.17%
- Stock Market
- Certificates
- Certificat
